Literature DB >> 2781512

Transient aggregation resistance of human blood platelets in fresh plasma. I. Methodology.

M R Hardeman1, J Vreeken, P T Goedhart, P R Oosting.   

Abstract

A novel analytical method, using turbidometry, for reporting the time-dependent decay in the threshold concentration of adenosine diphosphate (ADP), required to elicit a secondary aggregation response in fresh human citrated platelet-rich plasma (PRP), is described. The phenomenon, called "transient aggregation resistance" (TAR) ends, usually within one hour after venepuncture, in a steady state or "baseline aggregation resistance" (BAR). Back extrapolation of the mathematically transformed data to t = 0, yields a maximal threshold concentration of ADP, representing the initial aggregation resistance (TARmax) at the time of blood withdrawal, which threshold is usually many orders of magnitude higher than the BAR-value. The exponential decay of TAR can be characterized by its half-life (t1/2). Mixing fresh, rapidly prepared, plasma with PRP, kept long enough to show only the stable low BAR-value, could restore the initial high (transient) aggregation resistance found in fresh PRP, suggesting that it concerns a natural, labile plasmatic factor. One hour old PRP, deliberately made refractory to ADP, did not show the TAR phenomenon again, but had a higher BAR-value. It is suggested that the level of clinical relevance of these early in vitro aggregation measurements is higher than that of classical, delayed aggregometry (e.g. BAR-values).

Entities:  

Mesh:

Year:  1989        PMID: 2781512     DOI: 10.1016/0049-3848(89)90136-9

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

1.  The influence of time of storage, temperature of storage, platelet number in platelet-rich plasma, packed cell, mean platelet volume, hemoglobin concentration, age, and sex on platelet aggregation test.

Authors:  C H Ho; I H Chan
Journal:  Ann Hematol       Date:  1995-09       Impact factor: 3.673

2.  Perioperative changes of response to antiplatelet medication in vascular surgery patients.

Authors:  Thomas Hummel; Saskia Hannah Meves; Andreas Breuer-Kaiser; Jan-Ole Düsterwald; Dominic Mühlberger; Achim Mumme; Horst Neubauer
Journal:  PLoS One       Date:  2020-12-29       Impact factor: 3.240

3.  [Evaluation of treatment adaptation for low response to ASA in vascular surgery].

Authors:  T Hummel; S H Meves; A Breuer-Kaiser; J O Düsterwald; D Mühlberger; A Mumme; H Neubauer
Journal:  Chirurg       Date:  2021-07       Impact factor: 0.955

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.